ANTI-INFLIXIMAB (IFX) ANTIBODIES - ANVISA Registration 80102512585
Access comprehensive regulatory information for ANTI-INFLIXIMAB (IFX) ANTIBODIES in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102512585 and manufactured by manufacturer not specified. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including BODITECH MED INC., PROGENIKA BIOPHARMA S.L., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
INFLIXIMAB (IFX)
Quantum Blue® Infliximab
BUHLMANN LABORATORIES AG
80102511760
Mar 27, 2017
ANTI-INSULIN ANTIBODY
iFLASH – IAA
SHENZHEN YHLO BIOTECH CO., LTD.
80867150120
Aug 05, 2021
ANTI-INTRINSIC FACTOR ANTIBODY
ACCESS INTRINSIC FACTOR Ab QC
BECKMAN COULTER, INC.
10033120546
Jun 25, 2007
ANTI-SMOOTH MUSCLE ANTIBODY
iFlash-SMA IgG
SHENZHEN YHLO BIOTECH CO., LTD.
80867150104
Jul 15, 2021
ANTI-INTRINSIC FACTOR ANTIBODY
ACCESS INTRINSIC FACTOR Ab CALIBRATORS
BECKMAN COULTER, INC.
10033120545
Jun 25, 2007
ANTICORPOS ANTI-INFLIXIMAB (IFX)
LISA-TRACKER ANTI-INFLIXIMAB
BIOSYNEX SA
10338930315
Jul 22, 2024
ANTICORPOS ANTI-INFLIXIMAB (IFX)
Família AFIAS Total Anti-Infliximab
BODITECH MED INC.
10350840430
Nov 07, 2022
ANTICORPOS ANTI-INFLIXIMAB (IFX)
Família AFIAS Free Anti-Infliximab
BODITECH MED INC.
10350840427
Oct 27, 2022
ANTICORPOS ANTI-INFLIXIMAB (IFX)
PROMONITOR ANTI-IFX
PROGENIKA BIOPHARMA S.L.
80134860239
Jul 03, 2017